2025

PaedVacCOVID - safety of the BNT162b2 vaccine against the SARS-CoV-2 in children with and without comorbidities aged 5 to 11 years
Holzwarth S, Saadat K, Jorczyk M, Dreßen S, Kotsias-Konopelska S, Schlegtendal A, Maier C, Schmitt J, Paul K, Pagel J, Muntau A, Berner R, Brinkmann F, Toepfner N
INFECTION. 2025;53(2):615-624.

2023

Reduced Humoral and Cellular Immune Response to Primary COVID-19 mRNA Vaccination in Kidney Transplanted Children Aged 5–11 Years
Lalia J, Schild R, Lütgehetmann M, Dunay G, Kallinich T, Kobbe R, Massoud M, Oh J, Pietzsch L, Schulze-Sturm U, Schuetz C, Sibbertsen F, Speth F, Thieme S, Witkowski M, Berner R, Muntau A, Gersting S, Toepfner N, Pagel J, Paul K
VIRUSES-BASEL. 2023;15(7):1553.

2022

Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants
Bossung V, Lupatsii M, Dashdorj L, Tassiello O, Jonassen S, Pagel J, Demmert M, Wolf E, Rody A, Waschina S, Graspeuntner S, Rupp J, Härtel C
GUT MICROBES. 2022;14(1):2038855.

2021

Infants Younger Than 90 Days Admitted for Late-Onset Sepsis Display a Reduced Abundance of Regulatory T Cells
Fortmann I, Dammann M, Siller B, Humberg A, Demmert M, Tüshaus L, Lindert J, van Zandbergen V, Pagel J, Rupp J, Herting E, Härtel C
FRONT IMMUNOL. 2021;12:666447.

Chronisch-rezidivierende Gonarthritis und Autoimmunneutropenie
Fröhlich A, Lehmberg K, Pagel J, Peldschus K, Schoof B, Schulze-Sturm U, Speth F
arthritis + rheuma. 2021;41(6):387-392.

Hyperoxia/Hypoxia Exposure Primes a Sustained Pro-Inflammatory Profile of Preterm Infant Macrophages Upon LPS Stimulation
Twisselmann N, Pagel J, Künstner A, Weckmann M, Hartz A, Glaser K, Hilgendorff A, Göpel W, Busch H, Herting E, Weinberg J, Härtel C
FRONT IMMUNOL. 2021;12:762789.

2020

Lactobacillus Acidophilus/Bifidobacterium Infantis Probiotics Are Beneficial to Extremely Low Gestational Age Infants Fed Human Milk
Fortmann I, Marißen J, Siller B, Spiegler J, Humberg A, Hanke K, Faust K, Pagel J, Eyvazzadeh L, Brenner K, Roll C, Pirr S, Viemann D, Stavropoulou D, Henneke P, Tröger B, Körner T, Stein A, Derouet C, Zemlin M, Wieg C, Rupp J, Herting E, Göpel W, Härtel C
NUTRIENTS. 2020;12(3):.

Sepsis related mortality of extremely low gestational age newborns after the introduction of colonization screening for multi-drug resistant organisms
Härtel C, Faust K, Fortmann I, Humberg A, Pagel J, Haug C, Kühl R, Bohnhorst B, Pirr S, Viemann D, Simon A, Zemlin M, Poralla S, Müller A, Köstlin-Gille N, Gille C, Heckmann M, Rupp J, Herting E, Göpel W
ANTIMICROB RESIST IN. 2020;9(1):144.

Increased Regulatory T Cells Precede the Development of Bronchopulmonary Dysplasia in Preterm Infants
Pagel J, Twisselmann N, Rausch T, Waschina S, Hartz A, Steinbeis M, Olbertz J, Nagel K, Steinmetz A, Faust K, Demmert M, Göpel W, Herting E, Rupp J, Härtel C
FRONT IMMUNOL. 2020;11:565257.

Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy
Siegmund M, Pagel J, Scholz T, Rupp J, Härtel C, Lauten M
Molecular and cellular pediatrics. 2020;7(1):.

S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants
Willers M, Ulas T, Völlger L, Vogl T, Heinemann A, Pirr S, Pagel J, Fehlhaber B, Halle O, Schöning J, Schreek S, Löber U, Essex M, Hombach P, Graspeuntner S, Basic M, Bleich A, Cloppenborg-Schmidt K, Künzel S, Jonigk D, Rupp J, Hansen G, Förster R, Baines J, Härtel C, Schultze J, Forslund S, Roth J, Viemann D
GASTROENTEROLOGY. 2020;159(6):2130-2145.e5.

2019

Gut Dysbiosis With Bacilli Dominance and Accumulation of Fermentation Products Precedes Late-onset Sepsis in Preterm Infants
Graspeuntner S, Waschina S, Künzel S, Twisselmann N, Rausch T, Cloppenborg-Schmidt K, Zimmermann J, Viemann D, Herting E, Göpel W, Baines J, Kaleta C, Rupp J, Härtel C, Pagel J
CLIN INFECT DIS. 2019;69(2):268-277.

Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocol
Marißen J, Haiß A, Meyer C, Van Rossum T, Bünte L, Frommhold D, Gille C, Goedicke-Fritz S, Göpel W, Hudalla H, Pagel J, Pirr S, Siller B, Viemann D, Vens M, König I, Herting E, Zemlin M, Gehring S, Bork P, Henneke P, Härtel C
BMJ OPEN. 2019;9(11):e032617.

2018

Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5
Bezdjian A, Bruijnzeel H, Pagel J, Daniel S, Thomeer H
ANN OTO RHINOL LARYN. 2018;127(6):409-413.

Mannose-binding lectin and mannose-binding protein-associated serine protease 2 levels and infection in very-low-birth-weight infants
Hartz A, Schreiter L, Pagel J, Moser K, Wieg C, Grotheer A, Rupp J, Herting E, Göpel W, Härtel C
PEDIATR RES. 2018;84(1):134-138.

Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period
Schwarz J, Scheckenbach V, Kugel H, Spring B, Pagel J, Härtel C, Pauluschke-Fröhlich J, Peter A, Poets C, Gille C, Köstlin N
CLIN EXP IMMUNOL. 2018;191(3):328-337.

IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age
Twisselmann N, Bartsch Y, Pagel J, Wieg C, Hartz A, Ehlers M, Härtel C
FRONT IMMUNOL. 2018;9:3166.

2017

Lactobacillus acidophilus/Bifidobacterium infantis probiotics are associated with increased growth of VLBWI among those exposed to antibiotics
Härtel C, Pagel J, Spiegler J, Buma J, Henneke P, Zemlin M, Viemann D, Gille C, Gehring S, Frommhold D, Rupp J, Herting E, Göpel W
SCI REP-UK. 2017;7(1):5633.

The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants
Hartz A, Pagel J, Humberg A, Preuss M, Schreiter L, Rupp J, Figge J, Karsten C, Nürnberg P, Herting E, Göpel W, Härtel C
PLOS ONE. 2017;12(5):e0178032.

High Amounts of S100-Alarmins Confer Antimicrobial Activity on Human Breast Milk Targeting Pathogens Relevant in Neonatal Sepsis
Pirr S, Richter M, Fehlhaber B, Pagel J, Härtel C, Roth J, Vogl T, Viemann D
FRONT IMMUNOL. 2017;8:1822.

2016

NOD2 Loss-of-Function Mutations and Risks of Necrotizing Enterocolitis or Focal Intestinal Perforation in Very Low-birth-weight Infants
Härtel C, Hartz A, Pagel J, Rupp J, Stein A, Kribs A, Müller A, Haase R, Gille C, Böttger R, Kittel J, Jensen R, Wieg C, Herting E, Göpel W
INFLAMM BOWEL DIS. 2016;22(2):249-56.

Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis
Pagel J, Hartz A, Figge J, Gille C, Eschweiler S, Petersen K, Schreiter L, Hammer J, Karsten C, Friedrich D, Herting E, Göpel W, Rupp J, Härtel C
CLIN EXP IMMUNOL. 2016;185(2):219-27.

2015

FUT 2 polymorphism and outcome in very-low-birth-weight infants
Demmert M, Schaper A, Pagel J, Gebauer C, Emeis M, Heitmann F, Kribs A, Siegel J, Müller D, Keller-Wackerbauer A, Gerleve H, Wieg C, Herting E, Göpel W, Härtel C
PEDIATR RES. 2015;77(4):586-90.

Preterm prelabor rupture of membranes and outcome of very-low-birth-weight infants in the German Neonatal Network
Hanke K, Hartz A, Manz M, Bendiks M, Heitmann F, Orlikowsky T, Müller A, Olbertz D, Kühn T, Siegel J, von der Wense A, Wieg C, Kribs A, Stein A, Pagel J, Herting E, Göpel W, Härtel C
PLOS ONE. 2015;10(4):e0122564.

2014

Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants
Härtel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, Heckmann M, Franz A, Schiffmann J, Zimmermann B, Hepping N, von der Wense A, Wieg C, Herting E, Göpel W
J PEDIATR-US. 2014;165(2):285-289.e1.

Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots
la Marca G, Canessa C, Giocaliere E, Romano F, Malvagia S, Funghini S, Moriondo M, Valleriani C, Lippi F, Ombrone D, Della Bona M, Speckmann C, Borte S, Brodszki N, Gennery A, Weinacht K, Celmeli F, Pagel J, de Martino M, Guerrini R, Wittkowski H, Santisteban I, Bali P, Ikinciogullari A, Hershfield M, Notarangelo L, Resti M, Azzari C
J ALLERGY CLIN IMMUN. 2014;134(1):155-9.

2012

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)
Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs A, Al-Jefri A, Beier R, Lilian B, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B, Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, Zur Stadt U, Janka-Schaub G
BLOOD. 2012;119(25):6016-6024.

2010

Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases
Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, Bondzio I, Gross-Wieltsch U, Schündeln M, Schütz B, Woessmann W, Groll A, Strahm B, Pagel J, Speckmann C, Janka-Schaub G, Griffiths G, Schwarz K, Zur Stadt U, Ehl S
HAEMATOLOGICA. 2010;95(12):2080-2087.

2009

Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11
zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, Strauss J, Kasper B, Nürnberg G, Becker C, Maul-Pavicic A, Beutel K, Janka G, Griffiths G, Ehl S, Hennies H
AM J HUM GENET. 2009;85(4):482-492.

Letzte Aktualisierung aus dem FIS: 09.05.2025 - 00:34 Uhr